ClinConnect ClinConnect Logo
Search / Trial NCT06779032

Clinical Profile of Skin Aging Based on Dermoscopy Photoaging Scale and Glogau Scale - Study of Leucocyte Telomere Length, Biomarker P16, and Body Mass Index

Launched by INDONESIA UNIVERSITY · Jan 12, 2025

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Skin Aging Body Mass Index Triglycerides Waist Circumference Cellular Senescene P16

ClinConnect Summary

This clinical trial is studying how our skin ages, focusing specifically on people with certain skin types and examining different factors that may influence skin aging. Researchers want to understand the appearance of aging skin and how it relates to measurements like body weight, waist size, and certain biological markers. They will look at how these factors connect to the health of skin cells and how they change over time.

To participate in the study, women aged 31 to 61 who are generally healthy and willing to join are eligible. However, those with a history of serious health issues, like heart or liver diseases, or who are pregnant or breastfeeding cannot take part. If you join the trial, you can expect to undergo skin examinations and provide information about your health and lifestyle. This research aims to help us learn more about skin aging and how different factors might influence it, which could lead to better skin care strategies in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • female aged 31-61 years
  • healthy
  • willing to participate in the study
  • Exclusion Criteria:
  • history of diseases (heart, kidney, liver)
  • pregnant or breastfeeding patientes

About Indonesia University

Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.

Locations

Jakarta, Dki Jakarta, Indonesia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported